Résultats de la recherche

Search Pages webPDF

Les résultats s’affichent automatiquement selon le filtre sélectionné.

Filtres
Communiqué de presse
Forms
Manuel des politiques opérationnelles
(-) Page
Mots-clés
FAQ
Formulaires
Profil du fournisseur
628 résultat(s) trouvé(s)
Drug formulary listing decision – Benzodiazepines
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Drug formulary listing decision – Botulinumtoxin-A
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A  Indication(s)  OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Drug formulary listing decision – Buprenorphine for opioid use disorder
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Drug formulary listing decision – Buprenorphine in treatment of chronic pain
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…
Drug formulary listing decision – Calcitonin Gene-Related Peptide Monoclonal Antibodies in prevention of migraine
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…